Commission Regulation (EU) No 1154/2014 of 29 October 2014 refusing to authorise certain health claims made on foods, other than those referring to the reduction of disease risk and to children's development and health (Text with EEA relevance)
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
1. The health claims listed in the Annex to this Regulation shall not be included in the Union list of permitted claims as provided for in Article 13(3) of Regulation (EC) No 1924/2006. 2. However, the health claims referred to in paragraph 1 used prior to the entry into force of this Regulation, may continue to be used for a maximum period of six months after the entry into force of this Regulation.
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .
REJECTED HEALTH CLAIMS
ANNEX REJECTED HEALTH CLAIMS Application — Relevant provisions of Regulation (EC) No 1924/2006 Nutrient, substance, food or food category Claim EFSA opinion reference Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data Zinc Prevents bad breath by neutralising of volatile sulphur compounds (VSC) in the mouth and oral cavity. Q-2010-01092 Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data Yestimun® Daily administration of Yestimun® helps to maintain the body's defence against pathogens. Q-2012-00761 Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data Transitech® Improves transit and durably regulates it. Q-2013-00087 Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data Bimuno® GOS Regular daily consumption of 1,37 g galacto-oligosaccharides from Bimuno® may reduce abdominal discomfort. Q-2012-01007 Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data Lactobacillus rhamnosus GG Lactobacillus rhamnosus GG for maintaining normal defecation during oral antibiotic treatment. Q-2013-00015 Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data VeriSol®P Characteristic collagen peptide mixture (collagen hydrolysate) having a beneficial physiological effect on the maintenance of skin health, as indicated by an increased skin elasticity and a reduction of wrinkles volume, by contributing to a normal collagen and elastin synthesis. Q-2012-00839 Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data Proanthocyanidins in Urell® Proanthocyanidins from Urell® contribute to support defence against bacterial pathogens in the lower urinary tract Q-2012-00700 Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data Preservation® Improves the physiological response to stress by accelerating the appearance of heat shock proteins (HSPs) and maintains an effective level of HSPs to ensure that the organism is primed should the cell encounter further stress. Q-2013-00021
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.